The Food and Drug Administration approved a new drug on Thursday that may postpone the onset of Type 1 diabetes, becoming the first of its kind to delay the chronic condition.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.